A Study to Learn About the Safety and Efficacy of the Drug Oleogel-S10 in Japanese Patients With Epidermolysis Bullosa

NCT06917690 · clinicaltrials.gov ↗

PHASE3

Phase

RECRUITING

Status

6

Enrollment

INDUSTRY

Sponsor class

Conditions

Epidermolysis Bullosa
Junctional Epidermolysis Bullosa
Epidermolysis Bullosa, Dystrophic
Epidermolysis Bullosa, Junctional
Skin Abnormalities
Connective Tissue Disease
Collagen Diseases
Skin Diseases
Genetic Diseases, Inborn
Congenital Abnormalities

Interventions

DRUG: Oleogel-S10

Sponsor

Chiesi Farmaceutici S.p.A.